Two decades covering equity markets. Writes on single stocks, sectors, valuations and the trades behind the tape.

RBC Capital Markets sees Johnson & Johnson's drug business growing into 2027, with 14% ex-Stelara sales growth in Q2. The bank also expects

Latin American stocks and currencies eased as Brent crude rose above $85 a barrel and the US dollar strengthened. The MSCI Latin American st

Japan is investing $2.4 billion in a new consortium called Noetra, bringing together tech giants like SoftBank and Fujitsu to build AI for h

Wedbush predicts IMAX will report a softer second quarter as China ticket sales and a family-heavy US movie slate limit demand. The firm exp

Bank of America says Hasbro's Q2 results should land close to expectations, but the real story is how much profit comes from Magic: The Gath

Bank of America Securities says Alphabet heads into its Q2 earnings with steady ad revenue and a stronger-than-expected cloud business, boos

Fresh data on retail sales and jobless claims failed to clarify the Federal Reserve's next move, pushing Treasury yields slightly higher. Ma

Bank of America downgraded W.R. Berkley to underperform and cut its price target to $68, citing cooling commercial insurance pricing. The an

Abbott Laboratories raised its full-year 2026 earnings forecast after a second-quarter beat, powered by a 42% surge in diagnostics sales. Sh

SBI Funds Management's $1.03 billion IPO drew $31.1 billion in bids, with institutions oversubscribing their portion 140 times. The strong d

Pandora is testing platinum-plated jewelry in the Netherlands, aiming to cut silver price risk. But Bernstein warns the move could confuse c

Prologis raised its full-year profit forecast after a record quarter of warehouse leasing and a surge in data center projects. The logistics